Evaluation of Disease Status of Psoriatic Arthritis Using 23Na-MRI

Evaluation of Disease Status of Psoriatic Arthritis Using 23Na-MRI - Evaluation of Disease Status of Psoriatic Arthritis Using 23Na-MRI

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000055159

Enrollment

Registered

2024-08-05

Start date

2024-08-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psoriatic Arthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adult patients who meet CASPAR criteria 2. Patients with arthralgia 3. Patients with eGFR 60ml/min/1.73m2 or more

Exclusion criteria

Exclusion criteria: 1. Blood pressure >140/90mmHg at screening 2. HbA1c>6.5% at screening

Design outcomes

Primary

Measure	Time frame
Accumulation of sodium in skin evaluated by 23Na-MRI	—

Countries

Japan

Contacts

Public ContactKaoru Minegishi

Yokohama City University Graduate School of Medicine Department of Stem Cell and Immune Regulation

kaoru_t@yokohama-cu.ac.jp045-787-2630

Outcome results